Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The OTCBB Garbage Dump -- Ignore unavailable to you. Want to Upgrade?

To: Tom Allinder who wrote (2680)	10/7/1999 3:14:00 PM
From: MoonDog	Read Replies (1) \| Respond to of 2942

PCBM News .215 x .255 (PR NEWSWIRE) Pinnacle Business Management Details Large Growth in the 4th Pinnacle Business Management Details Large Growth in the 4th Quarter (www.pcbm.com) CLEARWATER, Fla., Oct. 7 /PRNewswire/ -- Pinnacle Business Management, Inc. (OTC Bulletin Board: PCBM) and Fast PayCheck Advances, Inc.(a wholly owned subsidiary of Pinnacle) announced today a brief update as to the progression of Pinnacle Business Management. Pinnacle has entered into an exclusive long-term contract with Mail Boxes Etc. The agreement has created a realistic opportunity for rapid expansion, growth, and profitability. Expansion through MBE locations gives PCBM immediate growth. Pinnacle CEO Jeff Turino added: "We plan to rollout 270 locations in Florida by year-end without the massive expenses associated with building or leasing locations and hiring additional staff. This association with Mail Boxes Etc. will provide PCBM unparalleled national exposure while bringing additional value to our shareholders". Target market assessments indicate that Mail Boxes Etc. customers and Pinnacle's pay day advance customers are congruent. Essentially, both parties can continue to prosper from this relationship. -- Currently, PCBM is in the midst of an independent audit to expedite the goal of becoming a full-reporting company. -- With the current relationships and continued endeavors, Pinnacle expects to show an operating profit in the fourth quarter. Safe Harbor for Forward-Looking Statements: Except for historical information contained herein, the statements in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the company's actual results in the future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition, risk inherent in the company's domestic and international operations, imprecision in estimating product reserves and the company's ability to replace and expand its holdings. For Investor relations contact Don or Cynthia Mandel of Mandel Consulting for Pinnacle Business Management, (954)-973-3493 or e-mail at don_mandel@yahoo.com. SOURCE Pinnacle Business Management, Inc. -0- 10/07/1999 /CONTACT: Don or Cindy Mandel, both of Mandel Consulting, 954-973-3493, or email, don_mandel@yahoo.com, for Pinnacle Business Management, Inc./ /Web site: pcbm.com (PCBM) CO: Pinnacle Business Management, Inc.; Fast PayCheck Advances, Inc.; Mail Boxes Etc. ST: Florida IN: FIN SU: * end of story *

To: Tom Allinder who wrote (2680)	10/7/1999 10:35:00 PM
From: LANCE B	Read Replies (2) \| Respond to of 2942

PRLN- BESIDES THE PHARMACY ON LINE NEWS; did you see this news released the day before.. Paracelsian Announces European Distribution Agreement for Dioxin Test Kit ITHACA, N.Y., Oct. 6 /PRNewswire/ -- Paracelsian, Inc. (OTC Bulletin Board: PRLN - news) announced today that it has signed a distribution agreement covering the European community with Belgium based Cypress Diagnostics CBVA for its patented Dioxin test, the Ah Immunoassay. The kit can be used to quickly, accurately and in a cost-efficient manner detect dioxin and dioxin-like compounds within incinerator ash, food, soil, water, or even the blood of wildlife or humans. Interest in monitoring Dioxins has increased dramatically throughout Europe since a Dioxin scare during the summer of 1999. This past June grocery stores in Belgium frantically pulled food products from store shelves after learning that a cancer-causing dioxin in animal feed had spread through the Belgian food chain. Paracelsian announced on July 15, 1999 the allowance of its latest patent application for the Ah Immunoassay. The assay is highly accurate and can be performed in the field in a fraction of the time and at a fraction of the cost of other Dioxin testing methods currently available. The company also has foreign patent applications pending for this same technology, including pending applications in Japan and Europe. Paracelsian is confident that these applications will result in further patents being issued for this unique technology. ''This quick, accurate, portable and inexpensive test for dioxin and dioxin-like compounds is the key technology driving Paracelsian's environmental business and provides a powerful new tool in the worldwide effort to monitor the presence of these highly toxic materials in our environment,' stated Bernie Landes, Paracelsian President and CEO. ''While we have established sales targets for the initial one year term of the agreement, we are even more excited about expanding both the geographic scope of our distribution and the range of applications for the Ah Immunoassay to include food, soil, water, milk, and human serum. With the signing of this agreement, with the agreement already in place with Kubota Corporation, and with discussions ongoing for additional distribution agreements covering the People's Republic of China, the balance of the Pacific Rim and Australia, we believe that the Ah Immunoassay will quickly become the gold standard for monitoring highly toxic Dioxins in the environment,' he added. Cypress Diagnostics is a privately held medical diagnostics company with worldwide product distribution. The Company has a direct sales force team in Germany, Austria, the Netherlands and Belgium and has developed a distribution network covering the balance of the Europe. Cypress Diagnostics has strategic alliances with partners in the forefront of immunological research and applied immunodiagnostics. Next Previous \| Previous \| Next \| Respond \| View 3 replies to this message View SubjectMarks Bookmark this Subject Discussion \| People \| MetaCrawler Subject Titles Only